Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
4062
Goto M, Chiba J, Matsuura M, Iwaki-Egawa S, Watanabe Y.
Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome.Intractable Rare Dis Res
2018
7:229-235
PubMed ID: 30560014
DOI: 10.5582/irdr.2018.01092
919
Makoto Goto, Junji Chiba, Masaaki Matsuura, Sachiko Iwaki-Egawa, Yasuhiro Watanabe
Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndromeIntractable Rare Dis Res
2016
5(2):103-8
PubMed ID: 27195193
DOI: 10.5582/irdr.2016.01028
12214
Sadahira Y, Sugihara T, Fujiwara H, Nishimura H, Suetsugu Y, Takeshita M, Okamura S, Goto M.
WRN protein as a novel erythroblast immunohistochemical marker with applications for the diagnosis of Werner syndromeVirchows Arch
2015
466(3):343-50
PubMed ID: 25503078
DOI: 10.1007/s00428-014-1703-6
918
M Goto, Y Ishikawa, M Sugimoto, Y Furuichi
Werner syndrome: a changing pattern of clinical manifestations in Japan (1917~2008)Biosci Trends
2013
7(1):13-22
PubMed ID: 23524889
920
M Goto, S Iwaki-Egawa, Y Watanabe
Ageing in Werner syndromeBiosci Trends
2012
6(1):33-7
PubMed ID: 22426101
DOI: 10.5582/bst.2012.v6.1.33